Is it safe to perform an erector spinae plane (ESP) block in a patient receiving therapeutic anticoagulation (e.g., warfarin, direct oral anticoagulants, low‑molecular‑weight heparin, unfractionated heparin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ESP Block in Anticoagulated Patients: Safety Assessment

The ESP block is generally acceptable in patients on anticoagulants because it is a superficial fascial plane block performed far from neuraxial structures and the pleura, making it substantially safer than neuraxial techniques. 1, 2

Why ESP Block is Safer Than Neuraxial Techniques

The ESP block is performed in the tissue plane between the erector spinae muscle and the transverse processes of thoracic vertebrae—a location that is anatomically distant from both the spinal cord and pleura. 3 This superficial placement minimizes the catastrophic risk of epidural hematoma that makes neuraxial blocks (epidural, spinal) contraindicated or high-risk in anticoagulated patients. 4

Key anatomical safety features:

  • The injection site is superficial and compressible, allowing direct pressure if bleeding occurs 1
  • No proximity to the neuraxis means epidural hematoma—which causes irreversible paralysis if not evacuated within 8-12 hours—is not a relevant risk 5, 6
  • The block avoids the pleural space, eliminating pneumothorax concerns 3

Clinical Evidence in Anticoagulated Patients

A case series specifically examined ESP blocks in 5 ICU patients with significantly altered hemostasis, including:

  • INR or aPTT >1.5 times normal
  • Platelet counts ≤80,000/μL
  • Active anticoagulation therapy

All patients achieved effective analgesia (≥70% pain reduction, 83% opioid reduction) with no neurologic or hemorrhagic complications during 5 days of surveillance. 1

Practical Approach to Anticoagulation Management

For patients on therapeutic anticoagulation:

  • The ESP block can be performed without stopping anticoagulation in most cases, given its superficial nature and compressibility 1
  • This contrasts sharply with neuraxial blocks, which require complete cessation of anticoagulation with specific timing windows 4

Specific anticoagulant considerations (if you choose to hold medications):

  • DOACs (rivaroxaban, apixaban, edoxaban): If electing to hold, stop 1-2 days before for low-bleeding-risk procedures when CrCl >30 mL/min 4
  • Dabigatran: Requires longer interruption (3-5 days depending on renal function) only if you're treating this as a moderate-risk procedure 4
  • Warfarin: Can proceed if INR ≤1.4, though this threshold applies to neuraxial blocks and is overly conservative for ESP 4, 5
  • LMWH prophylactic dose: Can proceed 12 hours after last dose if holding 4
  • Aspirin/NSAIDs: No interruption needed 4, 5

Critical Distinction from Neuraxial Guidelines

The French Working Group on Perioperative Hemostasis strongly recommends against neuraxial techniques in patients with possible DOAC concentrations, particularly those >80 years or with renal failure. 4 However, this recommendation specifically addresses "spinal or epidural anesthesia or deep-block techniques"—the ESP block does not fall into this high-risk category because it is a superficial interfascial plane block. 1, 2

When to Exercise Additional Caution

Consider delaying or using alternative analgesia if:

  • Platelet count <50,000/μL with active bleeding 4
  • Recent CNS bleeding or high risk for uncontrolled hemorrhage 4
  • Severe coagulopathy with INR >3.0 or multiple concurrent abnormalities requiring hematology consultation 4, 6

Post-procedure monitoring:

  • Assess the injection site for hematoma formation
  • Unlike neuraxial blocks, there is no need for serial neurologic exams to detect epidural hematoma 5, 6
  • The superficial location allows immediate identification and management of any bleeding complications 1

Resumption of Anticoagulation After ESP Block

Because the ESP block is not a neuraxial procedure, the stringent delays required after epidural catheter removal do not apply:

  • Prophylactic LMWH: Can resume 4-6 hours post-procedure 5
  • Therapeutic LMWH: Can resume 4 hours post-procedure 5
  • DOACs: Can resume 6 hours post-procedure 5
  • Warfarin: Can resume immediately once hemostasis confirmed 5, 6

These timelines are provided for reference but are more conservative than necessary for a superficial block like the ESP. 1

Bottom Line

The ESP block should be considered a preferred regional anesthesia technique for anticoagulated patients who require thoracic analgesia, as it provides effective pain control without the prohibitive bleeding risks associated with neuraxial approaches. 1, 2 The technique's safety profile, combined with its documented efficacy even in patients with severely altered hemostasis, makes it an excellent option when neuraxial blocks are contraindicated. 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anticoagulation Management After Lumbar Epidural Steroid Injection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guidelines for Neuraxial Anesthesia After Spine Instrumentation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Do you have to bridge warfarin (Coumadin) in outpatients?
Is the risk of bleeding higher when bridging with warfarin (Warfarin), Low Molecular Weight Heparin (LMWH), and clopidogrel (Clopidogrel) compared to being on warfarin (Warfarin) alone?
What is the recommended approach for bridging anticoagulation in patients on warfarin (International Normalized Ratio (INR)) prior to a procedure?
What is the approach for bridging anticoagulation in patients on warfarin (International Normalized Ratio (INR) antagonist) prior to a procedure?
How should I bridge a 63‑year‑old woman with a mechanical heart valve on warfarin (Coumadin) for an upcoming painful injection, including timing to stop warfarin, start therapeutic low‑molecular‑weight heparin, hold it before the procedure, and resume warfarin?
What is the recommended management for orthostatic hypotension, including non‑pharmacologic and pharmacologic options?
Can a patent foramen ovale cause a pulmonary embolism?
At 38 weeks gestation with a birth weight of 2,470 g, is the infant small for gestational age?
What is the recommended approach to managing diabetes in a patient with compensated or early decompensated cirrhosis, including lifestyle measures, safe pharmacologic agents, and monitoring?
What is the safest pharmacologic treatment for morning‑sickness nausea in a pregnant woman?
Can faropenem be used in pediatric patients older than 3 months weighing ≥10 kg, and what are the recommended dosage, treatment duration, and safety considerations?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.